Underrepresentation of women as participants and researchers in CV clinical trials remains a problem, asserts a review ...

The following is a summary of “Comparative Outcomes of Left Main and Non-Left Main Percutaneous Coronary Intervention from ...

Anti-CGRP antibodies vs onabotulinumtoxinA is not associated with increased cardiovascular disease risk in older patients ...

Advances in critical care therapies for patients with cardiogenic shock (CS), including temporary mechanical circulatory support and multidisciplinary shock teams, have led to improved survival to ...

Wearable devices can reduce cardiovascular events and death in ischemic heart disease, according to a new meta-analysis, but ...

The primary efficacy outcome was a composite of MACE and MALE, with MACE defined as myocardial infarction, ischemic stroke, and death from cardiovascular causes, and MALE defined as urgent ...

We aim to investigate the influence of sex on the timing and clinical outcomes of ST-segment elevation myocardial infarction (STEMI) patients using a controlled Swiss registry. Methods and results ...

Abstract: yocardial infarction (MI) stands as one of the most critical cardiac complications, occurring when blood flow to the cardiovascular system is partially or completely blocked.